雾芯科技涨近7%，悦刻发起电子烟安全性临床研究_老虎社区_美港股上老虎

雾芯科技涨近7%，悦刻发起电子烟安全性临床研究

老虎资讯综合2022-02-07

2月7日，雾芯科技涨近7%，雾芯科技旗下品牌RELX悦刻发起国内首个电子烟安全性临床研究。

RELX悦刻发起的电子烟安全性临床研究已在世界卫生组织国际临床试验注册平台一级机构——中国临床试验注册中心(ChiCTR)成功注册。据悉，这是国内首个聚焦“电子烟安全性”的临床研究，也是悦刻发起的第二个临床研究项目。2021年3月，悦刻曾成功申报国内首个电子烟临床研究。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

Johnm
·2022-02-09
Finally
回复
1
举报
收起
- Johnm:
  gd
  2022-03-15
  回复
  举报
echo_zz
·2022-02-08
想多了
回复
点赞
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1184088649?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/2edf9f40433de9411118b65473b80b0c","is_english":false,"pubTime":"2022-02-07 22:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184088649","market":"other","top_or_hot":-1,"title":"雾芯科技涨近7%，悦刻发起电子烟安全性临床研究","media":"老虎资讯综合","content":"<html><head></head><body><p>2月7日，雾芯科技涨近7%，雾芯科技旗下品牌RELX悦刻发起国内首个电子烟安全性临床研究。</p><p><img src=\"https://static.tigerbbs.com/59124d7917bb8a9e28eab9395e2053f0\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"/></p><p>RELX悦刻发起的电子烟安全性临床研究已在世界卫生组织国际临床试验注册平台一级机构——中国临床试验注册中心(ChiCTR)成功注册。据悉，这是国内首个聚焦“电子烟安全性”的临床研究，也是悦刻发起的第二个临床研究项目。2021年3月，悦刻曾成功申报国内首个电子烟临床研究。</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>雾芯科技涨近7%，悦刻发起电子烟安全性临床研究</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n雾芯科技涨近7%，悦刻发起电子烟安全性临床研究\n</h2>\n\n<h4 class=\"meta\">\n\n2022-02-07 22:42 北京时间&nbsp;&nbsp;&nbsp;<strong>老虎资讯综合</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2月7日，雾芯科技涨近7%，雾芯科技旗下品牌RELX悦刻发起国内首个电子烟安全性临床研究。RELX悦刻发起的电子烟安全性临床研究已在世界卫生组织国际临床试验注册平台一级机构——中国临床试验注册中心(ChiCTR)成功注册。据悉，这是国内首个聚焦“电子烟安全性”的临床研究，也是悦刻发起的第二个临床研究项目。2021年3月，悦刻曾成功申报国内首个电子烟临床研究。</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RLX","symbol_name":"雾芯科技","start_time":0,"source_url":"","article_id":"1184088649","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/2edf9f40433de9411118b65473b80b0c"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184088649","pubTimestamp":1644244933,"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"2月7日，雾芯科技涨近7%，雾芯科技旗下品牌RELX悦刻发起国内首个电子烟安全性临床研究。RELX悦刻发起的电子烟安全性临床研究已在世界卫生组织国际临床试验注册平台一级机构——中国临床试验注册中心(C","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"RLX":"雾芯科技"},"translate_title":"Fog Core Technology rose by nearly 7%, and Yueke launched a clinical study on the safety of e-cigarettes","themeId":"","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/0c50d730f88540bf236160c78bd65481","symbols_score_info":{"RLX":0.9},"content_text":"2月7日，雾芯科技涨近7%，雾芯科技旗下品牌RELX悦刻发起国内首个电子烟安全性临床研究。RELX悦刻发起的电子烟安全性临床研究已在世界卫生组织国际临床试验注册平台一级机构——中国临床试验注册中心(ChiCTR)成功注册。据悉，这是国内首个聚焦“电子烟安全性”的临床研究，也是悦刻发起的第二个临床研究项目。2021年3月，悦刻曾成功申报国内首个电子烟临床研究。","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[{"id":633745206,"gmtCreate":1644365132981,"gmtModify":1644365133125,"author":{"id":"3586224121384758","authorId":"3586224121384758","name":"Johnm","avatar":"https://static.tigerbbs.com/93c4fba34c3d41720ef28e4a521d9e1f","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3586224121384758","authorIdStr":"3586224121384758"},"htmlText":"Finally","listText":"Finally","text":"Finally","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/633745206","repostId":1184088649,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7294540,"gmtCreate":1647301435302,"gmtModify":1647307953663,"authorId":3586224121384758,"author":{"id":3586224121384758,"idStr":"3586224121384758","authorId":3586224121384758,"name":"Johnm","avatar":"https://static.tigerbbs.com/93c4fba34c3d41720ef28e4a521d9e1f","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":633745206,"type":1,"supId":0,"prevId":0,"content":"gd","text":"gd","html":"gd"}],"langContent":"CN"},{"id":633760794,"gmtCreate":1644329595650,"gmtModify":1644329595650,"author":{"id":"3561579634974103","authorId":"3561579634974103","name":"echo_zz","avatar":"https://static.tigerbbs.com/bdaeda5beb561f571d54594cbbb8014e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3561579634974103","authorIdStr":"3561579634974103"},"htmlText":"想多了","listText":"想多了","text":"想多了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/633760794","repostId":1184088649,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":16,"commentSize":2,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}